OMC
ADVM

Old Mission Capital’s Adverum Biotechnologies ADVM Stock Holding History

Old Mission Capital’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,590
Closed -$164K – 516
2020
Q3 		$164K Buy
+1,590
New +$238K 0.01% 403

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Old Mission Capital's ADVM Position: Q4 2020 in Review

Old Mission Capital sold out of Adverum Biotechnologies (ADVM) in Q4 2020, closing a stake of 1,590 shares — an estimated $164K sold.

Old Mission Capital first reported a position in ADVM in Q3 2020 and held it in 1 quarter. The position peaked at $164K in Q3 2020. 155 funds tracked by Wall St. Rank hold ADVM as of Q4 2020.

  • Old Mission Capital reported no remaining Adverum Biotechnologies position as of Q4 2020 after selling out during the quarter.
  • Old Mission Capital sold 1,590 Adverum Biotechnologies shares in Q4 2020, an estimated $164K.
  • Old Mission Capital first reported a position in Adverum Biotechnologies in Q3 2020 and held it in 1 quarter.
  • Old Mission Capital's Adverum Biotechnologies position peaked at $164K in Q3 2020.
  • 155 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2020.

Based on Old Mission Capital's 13F filing for Q4 2020, filed 17 Feb 2021.